I
The startup develops inhaled statin therapies for the treatment of chronic lung diseases, including COVID-19, asthma, and chronic obstructive pulmonary disease. By utilizing targeted inhalation delivery, the company aims to enhance drug efficacy and improve patient management in respiratory care.
Sacramento, United States
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup develops inhaled statin therapies for the treatment of chronic lung diseases, including COVID-19, asthma, and chronic obstructive pulmonary disease. By utilizing targeted inhalation delivery, the company aims to enhance drug efficacy and improve patient management in respiratory care.